The trademark application FYTIMRI was filed by Bristol-Myers Squibb Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on January 22, 2014, and it was registered by office on May 1, 2014 without any oppositions.
The application was filed in English (Spanish was selected as the second language).
The renewal of the trademark was recorded by the office on October 20, 2024.
of the trademark registration was recorded on October 20, 2024. Change of name and address of the trademark registration was recorded on January 24, 2022. Change of name and professional address of the trademark registration was recorded on February 3, 2022. Change of name and address of the trademark registration was recorded on October 11, 2023.